Additionally, three ICRGs (ADORA2A, CD226, and CD40) showed differently significant correlation with five SWDEGs in both diseases, which provided further insights into potential biological interactions and immune regulatory mechanisms underlying NASH and IBD. Here, CD226 is linked to inflammatory bowel disease.